Liqi He

516 total citations
5 papers, 253 citations indexed

About

Liqi He is a scholar working on Behavioral Neuroscience, Cardiology and Cardiovascular Medicine and Biological Psychiatry. According to data from OpenAlex, Liqi He has authored 5 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Behavioral Neuroscience, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Biological Psychiatry. Recurrent topics in Liqi He's work include Stress Responses and Cortisol (3 papers), Cardiomyopathy and Myosin Studies (2 papers) and Cellular Mechanics and Interactions (2 papers). Liqi He is often cited by papers focused on Stress Responses and Cortisol (3 papers), Cardiomyopathy and Myosin Studies (2 papers) and Cellular Mechanics and Interactions (2 papers). Liqi He collaborates with scholars based in United States and Germany. Liqi He's co-authors include Paul J. Gilligan, John Mcelroy, Ricardo M. Attar, George L. Trainor, Lawrence W. Fitzgerald, Becky Penhallow, Steven P. Seitz, Tai-An Lin, Paul Hartig and Ned H. Kalin and has published in prestigious journals such as Journal of Medicinal Chemistry, Psychopharmacology and Molecular Cancer Therapeutics.

In The Last Decade

Liqi He

5 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liqi He United States 5 103 71 69 61 43 5 253
Alexander Kirschner Germany 7 90 0.9× 237 3.3× 51 0.7× 33 0.5× 16 0.4× 9 390
Marilyn Jansen United States 8 17 0.2× 169 2.4× 28 0.4× 21 0.3× 144 3.3× 13 310
Yujuan La China 8 24 0.2× 169 2.4× 19 0.3× 122 2.0× 37 0.9× 8 318
Qiuying Shen China 7 58 0.6× 166 2.3× 11 0.2× 70 1.1× 89 2.1× 11 396
Thomas Bajaj Germany 6 50 0.5× 73 1.0× 12 0.2× 27 0.4× 8 0.2× 10 171
Kayo Takahashi Japan 11 29 0.3× 58 0.8× 6 0.1× 8 0.1× 19 0.4× 17 321
Andrew McMaster United Kingdom 6 41 0.4× 77 1.1× 8 0.1× 5 0.1× 44 1.0× 7 333
Shahzina Kanwal China 8 53 0.5× 129 1.8× 5 0.1× 78 1.3× 15 0.3× 10 250
Amber Lockridge United States 13 8 0.1× 180 2.5× 16 0.2× 12 0.2× 54 1.3× 19 334
Anthony L. Parola United States 6 13 0.1× 241 3.4× 7 0.1× 6 0.1× 138 3.2× 8 354

Countries citing papers authored by Liqi He

Since Specialization
Citations

This map shows the geographic impact of Liqi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liqi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liqi He more than expected).

Fields of papers citing papers by Liqi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liqi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liqi He. The network helps show where Liqi He may publish in the future.

Co-authorship network of co-authors of Liqi He

This figure shows the co-authorship network connecting the top 25 collaborators of Liqi He. A scholar is included among the top collaborators of Liqi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liqi He. Liqi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
He, Liqi, Steven P. Seitz, George L. Trainor, et al.. (2012). Modulation of cofilin phosphorylation by inhibition of the Lim family kinases. Bioorganic & Medicinal Chemistry Letters. 22(18). 5995–5998. 15 indexed citations
2.
Ross‐Macdonald, Petra, Heshani de Silva, Qi Guo, et al.. (2008). Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors. Molecular Cancer Therapeutics. 7(11). 3490–3498. 102 indexed citations
3.
4.
He, Liqi, Paul J. Gilligan, Robert Zaczek, et al.. (2000). 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2,4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine:  A Potent, Orally Bioavailable CRF1 Receptor Antagonist. Journal of Medicinal Chemistry. 43(3). 449–456. 94 indexed citations
5.
Gilligan, Paul J., Liqi He, Steven Culp, et al.. (1999). Structure–activity studies on 4-substituted-2-anilinopyrimidine corticotropin releasing factor (CRF) antagonists. Bioorganic & Medicinal Chemistry. 7(11). 2321–2328. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026